Literature DB >> 12069022

Antibiotic prescription rates vary markedly between 13 European countries.

Sigvard Mölstad1, Cecilia Stålsby Lundborg, Anna-Karin Karlsson, Otto Cars.   

Abstract

There is a lack of data on antibiotic utilization in most European countries. In this study, information about the number of antibiotic prescriptions was obtained for Austria, Belgium, Finland, France, Germany, Greece, Italy, The Netherlands, Portugal, Spain and the UK from the Institute for Medical Statistics Health Global Services in the UK. For Denmark and Sweden the information was obtained from the Danish Medicines Agency (Laegemiddelstyrelsen) and the National Corporation of Swedish Pharmacies (Apoteket AB), respectively. Between 1994 and 1997 the number of prescriptions per 1,000 inhabitants increased in France and Greece whilst Portugal, Spain and Sweden reported a decrease. In 1997, Greece (1,350), Spain (1,320) and Belgium (1,070) had the highest numbers of antibiotic prescriptions per 1,000 inhabitants in the Anatomical Therapeutic Chemical classification system for drugs group J01 while The Netherlands (390), Sweden (460) and Austria (480) had the lowest. The most common antibiotic drug was extended-spectrum penicillin in 6/13 countries, macrolides in Austria, Finland, Germany and Italy, phenoxymethylpenicillin in Denmark and Sweden and cephalosporins in Greece. The variation in the number of antibiotic prescriptions per 1,000 inhabitants between the 13 European countries was substantial in terms of both total use and use of different antibiotics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069022     DOI: 10.1080/00365540110080034

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  28 in total

1.  Utilisation of antibiotics in young children: opposite relationships to adult educational levels in Danish and Swedish counties.

Authors:  Eva Melander; Aase Nissen; Karin Henricson; Juan Merlo; Sigvard Mölstad; Jens P Kampmann; Thor Lithman; Ebba Holme Hansen; Arne Melander
Journal:  Eur J Clin Pharmacol       Date:  2003-07-15       Impact factor: 2.953

2.  European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach.

Authors:  R H Vander Stichele; M M Elseviers; M Ferech; S Blot; H Goossens
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

3.  The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy.

Authors:  D Boccia; S Spila Alegiani; A Pantosti; M L Moro; G Traversa
Journal:  Eur J Clin Pharmacol       Date:  2004-03-10       Impact factor: 2.953

4.  Assessing the impact of national antibiotic campaigns in Europe.

Authors:  M Filippini; L G González Ortiz; G Masiero
Journal:  Eur J Health Econ       Date:  2012-06-17

5.  Sales of systemic anti-infective agents in Cyprus in comparison with four other European countries.

Authors:  Christos Hadjimichael; Kyriacos Georgiou; George Samoutis; Evros Demetriades
Journal:  Pharm World Sci       Date:  2006-09-27

Review 6.  Social-economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare.

Authors:  Katarina Ilić; Emil Jakovljević; Vesna Skodrić-Trifunović
Journal:  Eur J Pediatr       Date:  2011-10-07       Impact factor: 3.183

7.  Safety and tolerability of clarithromycin administered to children at higher-than-recommended doses.

Authors:  D A Kafetzis; F Chantzi; G Tigani; C L Skevaki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

8.  A population-based study of different antibiotic prescribing in different areas.

Authors:  Katarina Hedin; Malin Andre; Anders Håkansson; Sigvard Mölstad; Nils Rodhe; Christer Petersson
Journal:  Br J Gen Pract       Date:  2006-09       Impact factor: 5.386

9.  Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain.

Authors:  Lars Bjerrum; Albert Boada; Josep M Cots; Carlos Llor; Dolors Forés Garcia; Bente Gahrn-Hansen; Anders Munck
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

10.  Problems in collecting comparable national drug use data in Europe: the example of antibacterials.

Authors:  Marit Rønning; Hege Salvesen Blix; Hanne Strøm; Eva Skovlund; Morten Andersen; Robert Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2003-03-18       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.